Literature DB >> 19319568

Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites.

Shigeki Sekine1, Yukihiro Nakanishi, Reiko Ogawa, Satoko Kouda, Yae Kanai.   

Abstract

Mucosal melanomas have genetic alterations distinct from those in cutaneous melanomas. For example, NRAS- and BRAF-activating mutations occur frequently in cutaneous melanomas, but not in mucosal melanomas. We examined 16 esophageal melanomas for genetic alterations in NRAS, BRAF, and KIT to determine whether they exhibit genetic features common to melanomas arising from other mucosal sites. A sequencing analysis identified NRAS mutations in six cases; notably, four of these mutations were located in exon 1, an uncommon mutation site in cutaneous and other mucosal melanomas. BRAF and KIT mutations were found in one case each. Immunohistochemistry showed KIT expression in four cases, including the tumor with a KIT mutation and two other intramucosal tumors. The low frequency of BRAF mutations and the presence of a KIT mutation-positive case are findings similar to those of mucosal melanomas of other sites, but the prevalence of NRAS mutations was even higher than that of cutaneous melanomas. The present study implies that esophageal melanomas have genetic alterations unique from those observed in other mucosal melanomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319568     DOI: 10.1007/s00428-009-0762-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.

Authors:  K T Montone; P van Belle; R Elenitsas; D E Elder
Journal:  Mod Pathol       Date:  1997-09       Impact factor: 7.842

2.  Major response to imatinib mesylate in KIT-mutated melanoma.

Authors:  F Stephen Hodi; Philip Friedlander; Christopher L Corless; Michael C Heinrich; Suzanne Mac Rae; Andrea Kruse; Jyothi Jagannathan; Annick D Van den Abbeele; Elsa F Velazquez; George D Demetri; David E Fisher
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

3.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  Argyrophil cells and melanocytes in esophageal mucosa.

Authors:  R Tateishi; H Taniguchi; A Wada; T Horai; K Taniguchi
Journal:  Arch Pathol       Date:  1974-08

5.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

Authors:  L J van 't Veer; B M Burgering; R Versteeg; A J Boot; D J Ruiter; S Osanto; P I Schrier; J L Bos
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

Review 6.  Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants.

Authors:  Thomas Hocker; Hensin Tsao
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

7.  KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.

Authors:  Filip Janku; Jan Novotny; Ivan Julis; Ivana Julisova; Ladislav Pecen; Vera Tomancova; Gabriela Kocmanova; Luboslava Krasna; Ivana Krajsova; Jiri Stork; Lubos Petruzelka
Journal:  Melanoma Res       Date:  2005-08       Impact factor: 3.599

8.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

9.  Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens.

Authors:  Christina M Lohmann; Wen Jen Hwu; Kristin Iversen; Achim A Jungbluth; Klaus J Busam
Journal:  Melanoma Res       Date:  2003-12       Impact factor: 3.599

10.  Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.

Authors:  Yoram Cohen; Eli Rosenbaum; Shahnaz Begum; David Goldenberg; Clemens Esche; Ofer Lavie; David Sidransky; William H Westra
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

View more
  8 in total

1.  Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Authors:  Jerzy Lasota; Artur Kowalik; Anna Felisiak-Golabek; Sebastian Zięba; Piotr Waloszczyk; Marek Masiuk; Jaroslaw Wejman; Justyna Szumilo; Markku Miettinen
Journal:  Mod Pathol       Date:  2019-02-13       Impact factor: 7.842

2.  Prevalence of NRAS Mutation, PD-L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.

Authors:  Hai-Yun Wang; Xiao-Yan Wu; Xiao Zhang; Xin-Hua Yang; Ya-Kang Long; Yan-Fen Feng; Fang Wang
Journal:  Oncologist       Date:  2019-10-02

3.  Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Authors:  Michael Lattanzi; Yesung Lee; Danny Simpson; Una Moran; Farbod Darvishian; Randie H Kim; Eva Hernando; David Polsky; Doug Hanniford; Richard Shapiro; Russell Berman; Anna C Pavlick; Melissa A Wilson; Tomas Kirchhoff; Jeffrey S Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

4.  Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.

Authors:  Haiyan Sun; Ningning Zhu; Lei Gong; Lan Lan; Zhentao Yu; Zhanyu Pan
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

Review 5.  The mutational landscape of mucosal melanoma.

Authors:  Kelsey W Nassar; Aik Choon Tan
Journal:  Semin Cancer Biol       Date:  2019-10-23       Impact factor: 15.707

6.  Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.

Authors:  Francis Shih; Stephen Yip; Patrick J McDonald; Albert E Chudley; Marc R Del Bigio
Journal:  Acta Neuropathol Commun       Date:  2014-10-21       Impact factor: 7.801

7.  Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.

Authors:  Yuan-Jun Cai; Long-Feng Ke; Wen-Wen Zhang; Jian-Ping Lu; Yan-Ping Chen
Journal:  BMC Cancer       Date:  2021-06-08       Impact factor: 4.430

8.  Prevalence of NRAS Mutation, PD-L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.

Authors:  Hai-Yun Wang; Xiao-Yan Wu; Xiao Zhang; Xin-Hua Yang; Ya-Kang Long; Yan-Fen Feng; Fang Wang
Journal:  Oncologist       Date:  2019-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.